INFU
Not that aggressive, and the more important question FY 15 analysts are in my range of eps. .27 fully taxed for a health care play Pop a 15 PE on it we see $4. In fact that analyst has a $6 price target, Which I think is too high.
Secondly it is 1 analyst, this is not like we have 7 guys coming up with that number. I use 18 Million in sales, use 71% GP margin, subtract 9.6 Million for operation expenses and 700k for interest expenses. Tax it by 40%, and see what you come up with. As I said before I could be wrong but that is my base case. But with earnings you never know. All is just my opinion, and I could always be wrong though.